Science & Tech

Every day, new innovations in technology and aging make the news. Whether it’s the way the science of epigenetics is redefining how and why we age or how big data, machine learning and artificial intelligence are taking the customer experience to the next level. This is where I share the disruptive new inventions that are helping us to live longer, healthier lives.

NYT: Pat Rilley Knows and Insurer Does Not

By Jon Sabes

Pat Riley Knows! Sorry, its not Pat Riley the famed NBA coach, but Pat Rilley, 77, from in Ann Arbor, Michigan who found that she had inherited an ApoE4 gene that increases the risk of developing Alzheimer’s disease, and bought a long-term care policy in response.  The New York Times article shows the flip-side of a […]

Read More

Willis Towers Watson Insurtech Briefing: Why InsurTech? A Pressured Insurance Value Chain

By Jon Sabes

From Willis Towers Watston Quarterly Insurtech Briefing: The Quarterly InsurTech Briefing Q1 2017 is out from Willis Towers Watson.  In the introduction, Rafal Walkiewicz, Chief Executive Officer of Willis Towers Watson Securities writes: Many market participants want to embrace the InsurTech revolution but continue to struggle with determining how to successfully monetize industry changes, at least in the short term. Should […]

Read More

The Economist: The World's Most Valuable Commodity is Now Data

By Jon Sabes

From The Economist: “A new commodity spawns a lucrative, fast-growing industry, prompting antitrust regulators to step in to restrain those who control its flow. A century ago, the resource in question was oil. Now similar concerns are being raised by the giants that deal in data, the oil of the digital era. These titans—Alphabet (Google’s […]

Read More

McKinsey Measures Where Insurtechs Are Focusing

By Jon Sabes
Read More

After the epigenome: The epitranscriptome

By Jon Sabes

As reported in Science Daily, researchers have published in Cancer Discovery that this RNA, the protein that is produced by our DNA, has its own spelling and grammar, just like DNA. The “epigenetics of RNA” are called epitranscriptome.  It was not too long ago when scientists did not even realize that there was such an […]

Read More

Epigenetic Labels Predict Increased Mortality

By Jon Sabes

You don’t have to take my word for it. For those who want to suggest that epigenetics does not offer predictive insights into aging and all-cause mortality, you probably can still join the Obama birther movement. As reported on WorldHealth.net, Scientists continue to serve up evidence that methyl labels in the DNA regulate the activity […]

Read More

PBS NewS Hour: Insurtech Epigenetic Life Insurance Company Begins Testing

By Jon Sabes

PBS News Hour picked up the story written by Rebecca Robbins at StatNews about how we are working to change the life insurance industry. While I can do without the macabre headline graphic (life, death & science is beautiful, not ghastly), the story does a great job on highlighting change that is occurring within the […]

Read More

genomeweb: Life Insurance Firm GWG Incorporates Epigenetic Mortality Predictor into Underwriting

By Jon Sabes

Life Insurance Firm GWG Incorporates Epigenetic Mortality Predictor into Underwriting Today, GenomeWeb published a report that as scientists discover more and more molecular biomarkers that can predict an individual’s disease and mortality risk, the results are not only applicable in personalized medicine but are also making their way into a new marketplace: the life insurance […]

Read More

Machines Will Save the Insurance Industry

By Jon Sabes

Bloomberg reports today that “Insurance companies are running out of ideas” and that the big rewards “will come from machines.”  I could not agree more, and that is exactly why I seek to take a run at the very heart of the business; as this is where the biggest rewards reside. Insurance companies stand to […]

Read More

ReFocus2017 Insurtech Genie is Out of the Bottle

By Jon Sabes

At the 11th annual global ReFocus2017 Conference, a panel of senior-level life insurance and reinsurance executives, jointly sponsored by the American Council of Life Insurers and the Society of Actuaries, discussed the impact of genetic and genomic testing on life insurance underwriting. After Day 1 where conference attendees were treated to a keynote speaker Dr. J. Craig Venter who spoke […]

Read More
Scroll to Top